Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 1
1950 1
1951 2
1952 2
1954 4
1955 1
1956 1
1957 1
1958 1
1959 2
1962 3
1965 1
1966 1
1968 2
1969 3
1970 2
1971 4
1972 6
1973 3
1974 3
1975 5
1976 8
1977 2
1978 6
1979 9
1980 7
1981 4
1982 4
1983 3
1984 12
1985 7
1986 3
1987 6
1988 6
1989 6
1990 5
1991 8
1992 7
1993 14
1994 13
1995 15
1996 17
1997 16
1998 9
1999 17
2000 15
2001 19
2002 15
2003 21
2004 20
2005 20
2006 19
2007 11
2008 24
2009 29
2010 18
2011 23
2012 33
2013 31
2014 29
2015 37
2016 34
2017 62
2018 56
2019 82
2020 142
2021 185
2022 176
2023 187
2024 212
2025 248
2026 91

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,912 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.
Chesney J, Lewis KD, Kluger H, Hamid O, Whitman E, Thomas S, Wermke M, Cusnir M, Domingo-Musibay E, Phan GQ, Kirkwood JM, Hassel JC, Orloff M, Larkin J, Weber J, Furness AJS, Khushalani NI, Medina T, Egger ME, Graf Finckenstein F, Jagasia M, Hari P, Sulur G, Shi W, Wu X, Sarnaik A. Chesney J, et al. J Immunother Cancer. 2022 Dec;10(12):e005755. doi: 10.1136/jitc-2022-005755. J Immunother Cancer. 2022. PMID: 36600653 Free PMC article. Clinical Trial.
Lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, demonstrated an investigator-assessed objective response rate (ORR) of 36% in 66 patients who progressed after ICI and targeted therapy. Herein, we report independent review committe …
Lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, demonstrated an investigator-assessed objective r …
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.
Betof Warner A, Hamid O, Komanduri K, Amaria R, Butler MO, Haanen J, Nikiforow S, Puzanov I, Sarnaik A, Bishop MR, Schoenfeld AJ. Betof Warner A, et al. J Immunother Cancer. 2024 Feb 29;12(2):e008735. doi: 10.1136/jitc-2023-008735. J Immunother Cancer. 2024. PMID: 38423748 Free PMC article. Review.
Adoptive cell therapy with autologous, ex vivo-expanded, tumor-infiltrating lymphocytes (TILs) is being investigated for treatment of solid tumors and has shown robust responses in clinical trials. ...This review includes clinical and toxicity management guidelines pertain …
Adoptive cell therapy with autologous, ex vivo-expanded, tumor-infiltrating lymphocytes (TILs) is being investigated for treatment of …
The rise of cochlear gene therapy.
Landegger LD, Reisinger E, Lallemend F, Hage SR, Grimm D, Cederroth CR. Landegger LD, et al. Mol Ther. 2025 Jun 4;33(6):2343-2349. doi: 10.1016/j.ymthe.2024.11.012. Epub 2024 Nov 8. Mol Ther. 2025. PMID: 39520052 Free PMC article. Review.
Recent evidence provides strong support for the safe and effective use of gene therapy in humans with hearing loss. By means of a single local injection of a set of adeno-associated virus (AAV) vectors, hearing was partially restored in several children with neurosensory n …
Recent evidence provides strong support for the safe and effective use of gene therapy in humans with hearing loss. By means of a sin …
Gerson Therapy (PDQ ): Patient Version.
PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. 2015 Jan 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2015 Jan 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389408 Free Books & Documents. Review.
This PDQ cancer information summary has current information about the use of Gerson therapy in the treatment of people with cancer. It is meant to inform and help patients, families, and caregivers. ...The information in this patient summary was taken from the healt …
This PDQ cancer information summary has current information about the use of Gerson therapy in the treatment of people with ca …
Migraine: disease characterisation, biomarkers, and precision medicine.
Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H, Schwedt TJ, Goadsby PJ. Ashina M, et al. Lancet. 2021 Apr 17;397(10283):1496-1504. doi: 10.1016/S0140-6736(20)32162-0. Epub 2021 Mar 25. Lancet. 2021. PMID: 33773610 Review.
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.
Fortuna GG, Banerjee R, Savid-Frontera C, Song J, Morán-Segura CM, Nguyen JV, Lekakis L, Fernandez-Pol S, Samraj AN, Naresh KN, Vazquez-Martinez M, Baz RC, Spiegel JY, Mikkilineni L, Gubatan JM, Sidana S, de Menezes Silva Corraes A, Kalariya NM, Patel KK, Shim KG, Fonseca R, Ferreri C, Voorhees PM, Richard S, Valdes CR, Sireesha Asoori, Wolf JL, Cowan AJ, Sborov DW, Locke FL, Lin Y, Wang Y, Hansen DK. Fortuna GG, et al. Blood Cancer J. 2024 Oct 16;14(1):180. doi: 10.1038/s41408-024-01167-8. Blood Cancer J. 2024. PMID: 39414769 Free PMC article.
We report 14 cases of immune effector cell (IEC)-associated enterocolitis following chimeric antigen receptor T-cell (CAR-T) therapy in multiple myeloma, with a 1.2% incidence overall (0.2% for idecabtagene vicleucel and 2.2% for ciltacabtagene autoleucel). ...In conclusio …
We report 14 cases of immune effector cell (IEC)-associated enterocolitis following chimeric antigen receptor T-cell (CAR-T) therapy …
Gerson Therapy (PDQ ): Health Professional Version.
PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. 2016 Apr 11. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2016 Apr 11. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389464 Free Books & Documents. Review.
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the use of Gerson therapy in the treatment of people with cancer. It is intended as a resource to inform and assist clinicians in the …
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the use …
Tumor-infiltrating lymphocytes: A new hope.
Sarnaik AA, Hwu P, Mulé JJ, Pilon-Thomas S. Sarnaik AA, et al. Cancer Cell. 2024 Aug 12;42(8):1315-1318. doi: 10.1016/j.ccell.2024.06.015. Epub 2024 Jul 18. Cancer Cell. 2024. PMID: 39029463 Free article. Review.
Here, we review the historical development of TIL therapy and discuss potential solutions to ongoing roadblocks that may result in broader and improved efficacy for patients afflicted with treatment-refractory, advanced cancer....
Here, we review the historical development of TIL therapy and discuss potential solutions to ongoing roadblocks that may result in br …
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, Lane R, Lim P, Duca AR, Hough D, Thase ME, Zajecka J, Winokur A, Divacka I, Fagiolini A, Cubala WJ, Bitter I, Blier P, Shelton RC, Molero P, Manji H, Drevets WC, Singh JB. Daly EJ, et al. JAMA Psychiatry. 2019 Sep 1;76(9):893-903. doi: 10.1001/jamapsychiatry.2019.1189. JAMA Psychiatry. 2019. PMID: 31166571 Free PMC article. Clinical Trial.
1,912 results